MCKESSON CORP (MCK)
NYSE • Healthcare
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About MCKESSON CORP
McKesson Corporation is a healthcare distribution and services company listed on the NYSE as MCK. It moves medicines and medical supplies through the healthcare system, with FY2026 revenue of $403.4 billion, spanning pharmaceutical distribution, medical-surgical supply, and technology-enabled access and support services.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
MCKESSON CORP's Technical Indicators Summary
MCK trades in the high-$800s and combines positive momentum with broad moving-average support, as price sits above most short- and long-term averages while MACD and momentum readings are constructive. Trend strength is moderate with ADX just above 20, volatility is typical with ATR near $26.8, and on-balance volume is not clearly supportive, creating one mixed input amid otherwise favorable technicals. Overall, the setup reflects alignment of price and momentum across multiple timeframes even as volume is ambiguous. Technical takeaway: Strong Buy — moving averages and momentum align bullishly, though trend strength is moderate.
| Indicator | Value |
|---|---|
RSI (14) | 55.21 |
Stochastic %K (14, 3, 3) | 54.30 |
CCI (20) | 45.65 |
WPR (14) | -42.55 |
Momentum (10) | 38.83 |
MFI | 46.32 |
MACD Level (12, 26) | 15.03 |
Bollinger Bands | $813.58 - $908.45 |
ATR (14) | $26.78 (3.08%) |
ADX (14) | 23.07 |
OBV | 211,250 |
Classic Pivot Point | $865.06 |
Fibonacci Pivot Point | $865.06 |
Simple Moving Averages | $811.44 - $873.34(5 indicators) |
Exponential Moving Averages | $819.93 - $867.08(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The last session saw the stock add a sliver of value, closing 1.09% above the previous day's 859.92. Barclays maintains MCK with Buy, raises target to $1,000, signaling upside.
Trading Volume
Below 10d avg (1.0M)
618.7K
vs S&P 500 Today
Outperforming Market
+1.78%
52-Week Position
Mid-range
60.2%
Updated: August 19, 2026 at 12:57 UTC
Quote Summary
MCK Headlines
Regulatory Cycles And Cybersecurity Leaders
May 19, 2026
Institutions Shift Positions In Major Health Stocks
February 27, 2026